Health
Pfizer’s vaccine offers COVID-19 protection after first dose, FDA says – Sydney Morning Herald
Pfizer has cleared the next hurdle in the race to get its COVID-19 vaccine approved for emergency use in the US.
The agency typically follows the recommendations of its advisory panels but is not required to do so.
The good news is that this very important part of the process is playing out just like it should and just like it does with every other FDA regulatory review process, said Dr Helen Boucher, Chief of Infectious Diseases at Tufts Medical Centre, in an interview with Reuters.
Data from the trial showed that the vaccine began conferring some protection to recipients even before they received the second…
-
General23 hours agoAxe falls on loggers’ plan to avoid battle over gliders
-
General21 hours agoBill Shorten believes Peter Dutton’s work-from-home policy backflip will cost him at election time
-
General21 hours agoAustralia looks to Asia, Europe amid US tariff turmoil
-
Noosa News21 hours ago$100 Million Cavill Avenue revamp set to reshape Surfers Paradise